Risk of malignancy in 22q11.2 deletion syndrome.

Toer StevensJutte van der Werff Ten BoschMarjan De RademaekerAnn Van Den BogaertMachiel van den Akker

Published in: Clinical case reports (2017)

22q11.2DS is a significant health problem because of its fairly high incidence. It is relevant to be vigilant regarding the diagnosis of cancer amongst 22q11.2 patients as there might be an increased risk, especially amongst patients with the 22q11.2 distal deletion syndrome.

Keyphrases

end stage renal disease
ejection fraction
healthcare
chronic kidney disease
newly diagnosed
case report
peritoneal dialysis
risk factors
mental health
prognostic factors
papillary thyroid
squamous cell
patient reported outcomes
young adults
health promotion